On average, patients at private equity purchased facilities had 25.4% more hospital-acquired conditions, according to the study published Dec. 26 in JAMA.
To get their results, researchers examined data from 662,095 hospitalizations at 51 private equity-acquired hospitals compared with more than 4.1 million hospitalizations at 259 matched control hospitals. They found that despite typically having a lower-risk patient population of Medicare beneficiaries, private equity-purchased hospital patients were still more likely to encounter adverse events.
Specifically, there was a nearly 38% increase in patients with central line–associated bloodstream infections at private equity hospitals and a 27% increase in falls. Surgical site infections for patients at these facilities were doubled, according to researchers, which they wrote, overall means a “poorer quality of inpatient care.”
“Such increases in hospital-acquired infections may result from decreased staffing, changes in operator technique, poorer clinician experience, increased patient illness, or other explanations,” the study authors wrote.
While hospital-acquired infections are typically associated with longer hospital stays, researchers found that not to be the case for private equity-purchased facilities. Instead, there was actually a slight decrease in length of stay for patients there.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.